Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

about

Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P

P2860

Q57788244-C526041C-9431-47CA-A33B-A3545D882AA9

P2860

Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

Item

http://www.wikidata.org/entity/Q45345117

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@en

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@nl

type

Item

label

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@en

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@nl

prefLabel

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@en

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@nl

P1476

Challenges and Opportunities w ...... ronidation from in Vitro Data.

@en

P2093

Ming Hu

http://www.w3.org/2001/XMLSchema#string

Shufan Ge

http://www.w3.org/2001/XMLSchema#string

Yifan Tu

http://www.w3.org/2001/XMLSchema#string

P2860

OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen

Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver

Can the pharmaceutical industry reduce attrition rates?

Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney.

Modulation of sinusoidal and canalicular elimination of bilirubin-glucuronides by rifampicin and other cholestatic drugs in a sandwich culture of rat hepatocytes.

Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells.

Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.

Effects of renal impairment on the pharmacokinetics of morinidazole: uptake transporter-mediated renal clearance of the conjugated metabolites

Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus

P2888

s40495-016-0076-8

P304

326-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40495-016-0076-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034341954

http://www.w3.org/2001/XMLSchema#string

P698

28966903

http://www.w3.org/2001/XMLSchema#string

P932

5613675

http://www.w3.org/2001/XMLSchema#string

Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

about

P2860

P2860

Challenges and Opportunities with Predicting in Vivo Phase II Metabolism via Glucuronidation from in Vitro Data.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932